Antonella Sistigu

Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.

Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

The added value of type I interferons to cytotoxic treatments of cancer.

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.

Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy.

Assessment of IFN-γ and granzyme-B production by in "sitro" technology.

Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodies.

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.

Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade.

Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.

Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers.

Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.

The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition.

The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation.

Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?

The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

3D cancer models: One step closer to human studies.

Epigenetics behind tumor immunology: a mini review.

Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.

In Vitro Evaluation of Cancer Cell Immunogenicity and Antigen-Specific T-Cell Cytotoxicity by Flow Cytometry.